Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Affected batches are positive for antibodies to hiv 1 and/or hiv 2 despite a claim on the package insert that the product is manufactured from serum or plasma that is negative for antibodies to hiv 1 and 2. there is no impact on the performance of the affected batches and the anti-hiv 1/2 positive stock used to manufacture the accurun 51 products us treated with beta propiolactone and uv radiation to reduce virus activity minimizing any safety risk.